Cost-effectiveness of high-dose edoxaban compared to adjusted-dose warfarin for prevention of stroke and systemic embolism in non-valvular atrial fibrillation

被引：0
|
作者：
Mearns, E. [1 ]
Doleh, Y. [2 ]
Coleman, C. I. [1 ]
机构：
[1] Hartford Hosp, Hartford, CT 06115 USA
[2] Univ Connecticut, Storrs, CT USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5110
引用
收藏
页码：896 / 896
页数：1
相关论文
共 50 条
  • [21] STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: SYSTEMATIC REVIEW OF COST-EFFECTIVENESS STUDIES
    Costa, S.
    Ramos, J. C.
    Braga, A. C.
    Pereira, J.
    VALUE IN HEALTH, 2013, 16 (07) : A531 - A531
  • [22] COST-EFFECTIVENESS OF RIVAROXABAN IN THE PREVENTION OF STROKE IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN ITALY
    Capri, S.
    Veneziano, M.
    Ricciardi, W. G.
    D'Ausilio, A.
    Pedone, M. P.
    Bianchi, C.
    VALUE IN HEALTH, 2013, 16 (07) : A525 - A526
  • [23] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    Current Cardiology Reports, 2015, 17
  • [24] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [25] The budget impact of left atrial appendage closure compared with adjusted-dose warfarin and dabigatran etexilate for stroke prevention in atrial fibrillation
    Amorosi, Stacey L.
    Armstrong, Shannon
    Da Deppo, Lisa
    Garfield, Susan
    Stein, Kenneth
    EUROPACE, 2014, 16 (08): : 1131 - 1136
  • [26] COST-EFFECTIVENESS OF RIVAROXABAN COMPARED WITH WARFARIN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION
    Kapur, A. K.
    Chatzitheofilou, I
    Schang, L. K.
    VALUE IN HEALTH, 2012, 15 (04) : A122 - A122
  • [27] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
    Freeman, James V.
    Zhu, Ruo P.
    Owens, Douglas K.
    Garber, Alan M.
    Hutton, David W.
    Go, Alan S.
    Wang, Paul J.
    Turakhia, Mintu P.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) : 1 - U129
  • [28] Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation
    Lip, Gregory Y. H.
    Lanitis, Tereza
    Kongnakorn, Thitima
    Phatak, Hemant
    Chalkiadaki, Corina
    Liu, Xianchen
    Kuznik, Andreas
    Lawrence, Jack
    Dorian, Paul
    CLINICAL THERAPEUTICS, 2015, 37 (11) : 2476 - 2488
  • [29] Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Mullin, Rachel
    Blazawski, Jon
    Coleman, Craig I.
    PLOS ONE, 2012, 7 (10):
  • [30] Cost-Effectiveness of Rivaroxaban Compared to Warfarin for Stroke Prevention in Atrial Fibrillation
    Lee, Soyon
    Anglade, Moise W.
    Dan Pham
    Pisacane, Robyn
    Kluger, Jeffrey
    Coleman, Craig I.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 845 - 851
12345